PROCEPT BioRobotics Corporation Common Stock is a medical technology company that specializes in robotic-assisted solutions for the treatment of prostate and kidney diseases. With its innovative Aquablation therapy, the company aims to transform the standard of care for patients and provide urologists with a precise, safe, and efficient treatment option.
